Angiogenesis, the development of new blood vessels, is an integral part of the body's physiology. It has a role in normal function-for example, in embryogenesis and in the menstrual cycle, but it is also important in pathological states. It may be beneficial as in wound healing, but may also contribute to the pathogenesis of some conditions-for example, tumour growth, neovascular glaucoma, and rheumatoid arthritis. Such diverse conditions may be grouped together as 'angiogenesis dependent diseases', and modulation of the angiogenic component in their pathogenesis may be used to control their progression.' One important aspect in the study of rheumatoid arthritis is the investigation of the potential role of angiogenesis in cartilage damage and the progressive joint destruction which characterises the disease. This review outlines the regulation of angiogenesis, associated aspects of endothelial cell function, the relation to the pathogenesis of rheumatoid arthritis, including cartilage damage, and the potential therapeutic implications.
The angiogenic response New vascular networks are generated through a number of stages that follow a set programme, which is apparently independent of the source of the stimulus.2 The process consists of seven distinct steps, which are summarised in fig 1.
Regulation of angiogenesis Angiogenesis is controlled by a variety of factors, most of which are small proteins. They include a variety of growth factors, prostaglandins, and some low molecular weight compounds. HEPARIN 
BINDING GROWTH FACTORS
As a result of studies on tumour angiogenesis it became clear that some growth factors could be identified by their affinity to heparin.3 A large number of angiogens have been isolated and studied as a result of this; they fall into two classes. Class I heparin binding growth factors have been shown to be anionic, [15] [16] [17] 000 Mr, and found in high levels in neural tissue. They include acidic fibroblast growth factor, endothelial cell growth factor,4 retina derived growth factor,5 and eye derived growth factor I1. and can produce reactive oxygen species using the enzyme xanthine oxidase, which is thought to be important in the pathogenesis of rheumatoid disease.90 These functions suggest that endothelial cells in the pannus tissue may actively contribute to, and help to maintain, the chronically inflamed state. Implications for existing treatments in rheumatoid arthritis The non-steroidal anti-inflammatory drug indomethacin has been shown to promote endothelial cell migration in culture.9 It inhibits angiogenesis, however, in the rat cornea in response to the implantation of adipose tissue92 or silver/potassium nitrate,93 and in the murine chronic granulomatous air pouch.94 It is suggested that this inhibition in the cornea may be due to suppression of prostaglandin E2 production, which has been shown to be angiogenic in analogues (which are inactive as anticoagulants) can inhibit the angiogenic response. This activity is independent of the mineralocorticoid or glucocorticoid activity of these molecules. Indeed some of these steroids-for example, tetrahydrocortisol, were thought to be biologically inactive before the discovery of this activity. They are thought. to act by the modulation of the production or breakdown of the basement membrane around the vessels involved in the angiogenic process,'04 though a direct action on endothelial migration in vitro has also been reported for tetrahydrocortisol and a heparin analogue.105 This A bacterial product, fumagillin, has been described, which was first shown to be a potent angiostatic in vitro."' Although this compound is toxic in vivo, a synthetic derivative has been produced, AGM1470, which has been used in vivo in the treatment of collagen II arthritis, 2 leading to an almost total obliteration of the disease (28/30 developed disease in the control group; only 1/19 developed arthritis in the treated group). This is so far the most dramatic demonstration of the potential effectiveness of such a therapeutic strategy.
Conclusions
Angiogenesis is an integral part of the pathogenesis of rheumatoid arthritis. The increased area of endothelium thus generated may play an important part in the development and maintenance of the chronically inflamed state. 
